Healthcare Foods

CFBANQUE Investment confirms the BB rating assigned to Healthcare Foods (STL2080.DS), an operator in the Healthcare sector based in Tanzania. This credit opinion reflects a speculative profile with heightened sensitivity to the economic cycle, refinancing conditions and input price volatility.

From a fundamental standpoint, the issuer posts an EBITDA margin of 55.3% which sits at the upper end of the sector range and evidences robust pricing power and exhibits a contained net leverage of 1.21x EBITDA, providing comfortable headroom to absorb capital expenditure and debt servicing. With revenues of $8.59B and a market capitalisation of $7.01B, Healthcare Foods commands a significant economic footprint within its domestic market.

Our proprietary models assign a Debt Capacity score of 700/1000, an Investment score of 591/1000 and an ESG & Governance score of 400/1000, reflecting a solid debt coverage, a measured investment potential and governance workstreams that need to be deepened.

The Positive outlook reflects our expectation of a gradual improvement in the credit profile over a 12 to 18 month horizon, subject to the execution of the strategic plan communicated by the issuer. This analysis stems from the combined review of our quantitative models and the qualitative judgement of the CFBANQUE Investment rating committee, and may be updated in line with the evolution of fundamentals or the regional macroeconomic environment.